Open Orphan PLC - Publication of positive results

Cathal Friel, Executive Chairman of Open Orphan and Doctor Andrew Catchpole, Chief Scientist at hVIVO discuss the publication of positive results of a Phase IIb field study of FLU-v 003 and it's significance as well as the new hVIVO contract signed with a European Biotech Company.

Cathal Friel
Executive Chairman
Dr. Andrew Catchpole
Chief Scientist

Company Events - OPEN ORPHAN

Open Orphan Presentation

Cathal Friel, CEO

Wed, 9 Oct 2019, 7:00am BST